ProText Mobility Inc (TXTM)

[badbadbad]

AWESOME DD ON TXTM by STEVRC


Huge TXTM South Africa Department of Health Endorsement

TXTM is an investment that is being setup to help an entire country (South Africa). The market is a little slow in seeing it right now, but I think as more is confirmed and learned by more investors, they will see the magnitude of what's being built here. All should read this 8-K below of the Share Exchange Agreement that closed the TXTM acquisition of Plandaí Biotechnology South Africa (SA):
http://ih.advfn.com/p.php?pid=nmona&article=73652133

Current Report Filing (8-k)
ih.advfn.com
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section ...



This is huge in my opinion since now Plandaí Biotechnology SA is a wholly-owned subsidiary of TXTM and will be one of the vehicles used for the Cannabis/Marijuana projects in South Africa.

Below is huge confirmation the South Africa Department of Health endorsement of TXTM through its wholly-owned subsidiary, Plandaí Biotechnology SA which now belongs to TXTM:
Quote:

Plandai Biotechnology, Inc. Announces South African Department of Health Endorses Access to Medicinal Cannabis / Move may provide an opportunity for Plandai's research to move forward in South Africa
http://www.finanznachrichten.de/nachrichten-2016-12/39399286-plandai-biotechnology-inc-announces-south-african-department-of-health-endorses-access-to-medicinal-cannabis-move-may-provide-an-opportunity-for-p-256.htm
Plandai Biotechnology, Inc. Announces South African ...
www.finanznachrichten.de
Plandai Biotechnology, Inc. Announces South African Department of Health Endorses Access to Medicinal Cannabis / Move may provide an opportunity for Plandai's ...



http://www.health.gov.za/

http://www.gov.za/welcome-official-government-online-site

v/r
Sterling
Private Reply | Keep | Public Reply | View Replies (3) | Mark as Last Read

stervc Member Profile stervc Member Level Friday, May 26, 2017 8:03:41 PM
Re: stervc post# 39589 Post #
39590
of 39627 Go
TXTM - The Setup for Worldwide Monopoly...

Courtesy of DD_dempsey, I think these are must read TXTM posts that highlight much of what the company can transform into:

TXTM - The Setup for Worldwide Monopoly
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=128140657
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128283294

v/r
Sterling
Private Reply | Keep | Public Reply | View Replies (1) | Mark as Last Read

stervc Member Profile stervc Member Level Friday, May 26, 2017 8:11:51 PM
Re: stervc post# 39590 Post #
39591
of 39627 Go
Very Important TXTM Government MJ Confirmation

The magnitude of what could be happening here with TXTM really stuck out to me even more after I read what Jason O'Donoghue had stated regarding Plandai which is basically paving the way for TXTM. Before reading this piece of info, understand that Jason O'Donoghue is a well known cannabis activist and the founder of South African Cannabis Community & Regulatory Associations ( SACCRA):

http://saccralobby.wixsite.com/saccra

Quote:

http://www.greenseadistribution.com/products/index.php/2016/12/04/south-africa-legalizes-medical-marijuana/


This part stood out to me too indicating that Plandai SA (TXTM) actually owns the patented process by which Medical Marijuana (MMJ) will be made legal for use in South Africa:
Quote:

http://i420.co.za/2016/06/28/south-africas-fight-for-legalisation-part-1/


v/r
Sterling
Private Reply | Keep | Public Reply | View Replies (1) | Mark as Last Read

stervc Member Profile stervc Member Level Friday, May 26, 2017 8:22:11 PM
Re: stervc post# 39591 Post #
39592
of 39627 Go
TXTM Patent Confirmation of its Phytofare®

Courtesy of OneBrokeMama, the links below indicates and confirms the patent for Phytofare® that now belongs to TXTM (Plandaí Biotechnology South Africa (SA)):
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128356423

The patent for Phytofare® has a ”WO” Patent Number (WO2013122890A1) which means that it is... a patent number that indicates that the original patent application was filed under the Patent Cooperation Treaty, an international treaty that harmonizes the patent application process among member nations:
http://info.legalzoom.com/wo-patent-20217.html

The above is why finding the patent for Phytofare® was a little difficult to find, but now officially confirms its legitimacy on the next few levels within the medical world for licensing and distribution rights for TXTM (Plandaí Biotechnology SA).
Quote:

https://patents.google.com/patent/WO2013122890A1/en?inventor=Roger+Duffield


Bioavailability of a substance relates to the amounts of the substance absorbed into the bloodstream and therefore to the availability of the substance for use by target tissues and cells in the body.

According to the Physician's Desk Reference, the absorption ratio of nutrients formulated into oral supplements as pills, tablets or soft gels varies between 1 -30%. Therefore, the real challenge is to overcome this problem of poor absorption and to efficiently transport and release the nutrients into the cells in order for the cells to do their healing work.

An objective of aspects of this process is to increase the bioavailability of phytonutrients from live plant materials.

v/r
Sterling
Private Reply | Keep | Public Reply | View Replies (2) | Mark as Last Read

stervc Member Profile stervc Member Level Friday, May 26, 2017 8:24:49 PM
Re: stervc post# 39592 Post #
39593
of 39627 Go
Significant TXTM Deregister Logic & Justification…

TXTM made the decision on Jan 27, 2017 to file a Form 15-12g with the SEC under Section 15/Rule 12g to deregister their shares with the SEC:
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11804450

This was when TXTM made the decision to simply continue to trade under the guidelines of the OTC Markets and be categorized the Alternative Reporting Standard as listed below:
http://www.otcmarkets.com/marketplaces/otc-pink

The purpose of the filing of a Form 15-12g is only to terminate or legally suspend the ”mandatory” duty of the company from having to file reports with the SEC. This is done for positive reasons to benefit the company as this is an outstanding article below justifying why a company would choose the Alternative Reporting Standard reporting requirement:
http://www.reversemergers101.com/going-dark-reverse-mergers/

Most pink sheet stocks that many investors trade/invest in are already deregistered with the SEC and … investors just don’t know or realize it. It just means that they will not be required to file 10-Qs, 10-Ks, 8-Ks, and/or any other reports per SEC requirements; primarily, audited financials won’t be required to file with the SEC or have to be completed by a Certified Public Accountant (CPA) to meet transparency qualifications as long as the financials are Consolidated Financials that are presented in Generally Accepted Accounting Principles (GAAP) format.

This is a huge savings for the company to where they are saving themselves lots of money that they can now allocate those funds more towards operational growth instead. Before financials are released, the CEOs or someone within the management of the company will always review the financials before they are submitted so they usually understand how things are to be logged. This means that now under this Alternative Reporting Standard requirement, they can sign off on their own financials as long as they are Consolidated Financials in GAAP format.

The key thing about being deregistered is the fear that this will create a lack of transparency. To fix the lack of transparency issue, this is why companies elect to trade on the pink sheets within the OTC Markets realm as this is also recognized as a now respected market arena for transparency. The OTC Market requirements come in to offer a cheaper form of transparency. Instead of filing a 10-Q the company will file a Quarterly Report. All 10-Qs and Quarterly Reports are “unaudited” regardless of the exchange. Instead of filing an ”audited” 10-K the company will file an ”unaudited” Annual Report.

So in summary… ALL financial reports can now be unaudited and will be fine for meeting transparency standards.

Understand, transparency is one of the main reasons why a stock generally files with the SEC that trades, but now with the emergence of the OTC Markets being respected by the SEC and many investors throughout for delivering transparency, many companies have chosen this route, especially since it is a much cheaper transparency standard to adhere to. Many companies have accepted this throughout as another means of existing to prove its legitimacy without having to file costly audited financials until being able to afford filing such or if such ever becomes desired. By all means, I’m not trying to downplay audited financials, but until a company is either significantly operational or near being operational to where huge revenues/profits are generated, then money should be saved by taking the OTC Markets route for transparency until such time. Even still after generating millions of dollars, some companies still elect to remain on the OTC Markets within the US Markets such as explained in the examples of what some more popular companies have chosen to do such as Nestle Chocolate (NSRGF), Rolls-Royce Holdings PLC (RYCEY), Swisscom AG (SCMWY), and a variety of other stocks indicated within the post below that were trading at such time between $11.00 to $95.00 per share ranges:

OTC Markets vs Fully Reporting SEC Status
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85598739

Again, this is really not such a big deal as it positions the company to not be required to SEC filing requirements and to not be subjected to the cost and time constraints involved until they are financially ready to do so in the future if ever deciding to do so. Some companies have decided to always remain within the OTC Markets within the US Markets which often proves to be fine too. Important to understand, any news of substance will be recognized just the same by investors with or without this deregistration. Big news will be recognized as big news regardless. This move is basically a norm that many companies are now implementing.

So in short, I still believe we are fine here with TXTM filing their Form 15-12g on Jan 27, 2017 with the SEC.

DEFINITION OF SEC FORM 15
Quote:

http://www.investopedia.com/terms/s/sec-form-15.asp
A filing with the Securities and Exchange Commission (SEC), also known as the Certification and Notice of Termination of Registration. It is used by publicly traded companies to revoke the registration of their securities. SEC Form 15 may also be used to notify the SEC and investors of a company's intent to cease filing various required forms because their securities no longer fall under certain filing requirements.

v/r
Sterling
Private Reply | Keep | Public Reply | View Replies (1) | Mark as Last Read

stervc Member Profile stervc Member Level Friday, May 26, 2017 8:28:59 PM
Re: stervc post# 39593 Post #
39594
of 39627 Go
TXTM**Huge Relationship Dots to Connect...

It appears that Plandaí Biotechnology South Africa (SA) is going to be the connection to connect TXTM as its Parent Company to the Marijuana/Cannabis Industry. Consider a past relationship that was established below that might be of some merit going forward in the future.

Jamen Shively is a former Microsoft (MSFT) manager and was one of the co-founders of DPWW (Diego Pellicer Worldwide ). Read below what he stated about Phytofare back when a deal was done with DPWW which permit DPWW to use of the Diego Pellicer name for its Phytofare™ cannabis extracts in medical and pharmaceutical marijuana applications:
Quote:

http://www.marketwired.com/press-release/plandai-biotechnology-inc-acquire-license-diego-pellicer-brand-medical-pharmaceutical-otcqb-plpl-1869780.htm
Jamen Shively, co-founder of Diego Pellicer, added, "We couldn't be happier with our partnership with Plandaí. Their Phytofare™ technology appears to be years ahead of the competition as it relates to bioavailability and will help anchor the Diego brand as more states legalize cannabis for medical and/or recreational applications. Plandaí can provide pharmaceutical-grade extracts, with or without psychoactive properties, that will significantly lower costs to the end customer, which is critically important for medical cannabis, as well as provide superior products. In addition, adverse side effects and risks of overconsumption will be greatly mitigated, by providing higher purity, with substantially lower dosage requirements for achieving a desired outcome."

Quote:

https://diego-pellicer.com/


Quote:

http://www.marketwired.com/press-release/plandai-biotechnology-inc-acquire-license-diego-pellicer-brand-medical-pharmaceutical-otcqb-plpl-1869780.htm
Diego Pellicer Inc. which was cofounded by the great grandson of Diego Pellicer, the former Vice Governor of the Island of Cebu the Philippines, has created the most recognized brand of cannabis in the world, building on the legacy of Vice Governor Pellicer, who was the largest grower of hemp in the world in the late 1800s, supplying hemp rope to the Spanish Armada during the Spanish American War.

Roger Baylis-Duffield, Chairman and Chief Executive Officer of Plandaí Biotechnology, commented, "Diego Pellicer has been the leading name in cannabis products for over a hundred years and represents everything that Plandaí stands for from a product standpoint; namely, an exhaustive dedication to quality. Being able to sell the Plandaí cannabinoid extracts under the Diego Pellicer name brings immediate name recognition and branding into the medicinal cannabis industry."

The new Diego Pellicer Gold™ cannabinoid extracts provides for efficient recovery of highly bioavailable and active antioxidants from live plant materials in a mainly nano particle form. The cannabinoids, including ?9-THC (Delta 9-THC) and CBDs are then delivered in a Pheroid®-protected state to the white blood cells without degradation or metabolization.

For medical and recreational applications where the metabolization of THC is preferred, such as in treating chronic pain, the Pheroid® entrapment step will be omitted, resulting in a highly bioavailable cannabinoid extract that will result in significantly lower required dosages. Plandaí anticipates producing both capsules and cannabis oil (for vapor use) in Pheroid™ and non-Pheroid™ versions with the immediate goal of generating nutraceutical sales while pursuing eventual FDA clearance for pharmaceutical applications.

v/r
Sterling
Private Reply | Keep | Public Reply | View Replies (1) | Mark as Last Read

stervc Member Profile stervc Member Level Friday, May 26, 2017 8:48:06 PM
Re: stervc post# 39594 Post #
39595
of 39627 Go
TXTM, US Government, Stem Cell, Bone Marrow, Marijuana Connection

Read this post below and pay particular attention to what I have highlighted in green in the last paragraph:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128222647

Now read this post courtesy of DD_dempsey, to further understand the connections of the South African Government to the US Government and how TXTM - Plandaí Biotechnology South Africa (SA) is helping to write the legislation for the South African Government:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128283294

The US Government is very aware of what TXTM has and what they are doing. This is why they made certain reference in the past to being connected through the US Marijuana Patent below:
Quote:

http://i420.co.za/2016/06/28/south-africas-fight-for-legalisation-part-1/
Plandai Biotechnology has to operate under license to the U.S. government who have owned the “worldwide patent on cannabinoids” since 2003. Now, although this is unnatural, unconstitutional and a violation of every civil liberty known to man, they have legislated this into effect worldwide through International treaties such as the UNSCND.

http://saccralobby.wixsite.com/saccra/single-post/2016/09/04/SACCRA-STANCE-ON-THE-IFP-SPONSORED-AMBROSINI-MEDICAL-INNOVATIONS-BILL


http://saccralobby.wixsite.com/saccra/single-post/2016/09/04/SACCRA-STANCE-ON-THE-IFP-SPONSORED-AMBROSINI-MEDICAL-INNOVATIONS-BILL
"In addition, through Plandaí's agreement with North West University, South Africa, the company holds the world license to the Pheroid® patented entrapment system to deliver protected Phytofare™ antioxidants to the white blood cells” and it is easy to see who and what is trying to monopolise Cannabis production in this country and the globe.

The beauty about Phytofare® is that this is what belongs to TXTM and is what will allow for Marijuana (THC & CBD) to be directly implanted into the white blood cells which will cause an immediate help towards fighting a variety of cancers and many other serious illnesses from what is mentioned towards the latter part of the post below:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128361961
Quote:

http://www.plandaibiotech.com/cannabis_cancer.html
Cannabis

CANCER

To date, cannabinoids have been successfully used in the treatment of nausea and vomiting, two common side effects that accompany chemotherapy in cancer patients. Nevertheless, the use of cannabinoids in oncology might be somehow underestimated since increasing evidence exists that shows plant, synthetic, and endogenous cannabinoids (endocannabinoids) are able to exert a growth-inhibitory action on various cancer cell types. ?9-Tetrahydrocannabinol (THC) exhibits the antitumor effects of apoptosis, cytostatic, and necrotic effects on various cancer cell types, but its use in chemotherapy is limited to its psychotropic activity. After the discovery of the two specific molecular targets for THC (CB1 and CB2 receptors) the five main natural compounds of cannabis were tested. It was then determined that cannabidiol (CBD) is the most potent inhibitor of cancer cell growth. CBD counteracts tumorous cell growth as well as inducing apoptosis, whereas THC primarily induces apoptosis in tumorous cells resulting in diminished tumor size. While the mechanisms of action of THC and CBD are distinct from one another, their synergy may produce a powerful treatment for various cancers including gliomas and malignancies of the immune system. Therefore using a combination of THC and CBD cannabinoids in botanical drugs targeting cancers may significantly enhance the efficacy of tumor killing.

I believe this could take place in the form of a stem cell transplant or a bone marrow transplant as talked about below:
Quote:

http://www.cancer.net/navigating-cancer-care/how-cancer-treated/bone-marrowstem-cell-transplantation/what-stem-cell-transplant-bone-marrow-transplant
A stem cell transplant is a treatment for some types of cancer. For example, you might have one if you have leukemia, multiple myeloma, or some types of lymphoma. Doctors also treat some blood diseases with stem cell transplants.

People get injections of a medication to raise their number of white blood cells. White blood cells help your body fight infections.

The health care team gives your donor injections of a medication to increase white cells in the blood, if the cells are collected from blood. Some donors will donate bone marrow in the operating room during a procedure which takes several hours.

TXTM already has the infrastructure, the personnel, the big name connections, the land/property, the experience, the South Africa Government, the US Government, and more in place and on their TEAM. This is why they won't fail and will very much succeed in my opinion.

All should re-read your post below as you have articulated what I have posted in an oh so much more simple understand to understand for those who are still not seeing the beauty of what we have here in TXTM (Plandaí Biotechnology South Africa):
Quote:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128370192
This Patent is key for TXTM because South Africa is legalizing cannabinoids for medical use. They are not legalizing Marijuana in general.

If I understand it correctly this patented "Phytofare" process allows Plandai to extract the cannabinoids in a way that make them more readily absorbed by the body.

We already have a working relationship in South Africa using the Phytofare process on green tea.

AND the company has already been doing cannabis research since 2014 in Uruguay.

Once the law is passed TXTM can hit the ground running!

v/r
Sterling

https://investorshub.advfn.com/boards/read_msgs.aspx?board_id=9720&NextStart=39585&BatchSize=10